Huang, Y M <br/><br/>
Multiple sclerosis: interferon-beta induces CD123(+)BDCA2- dendritic cells that produce IL-6 and IL-10 and have no enhanced type I interferon production.  [electronic resource] 

 -  Journal of neuroimmunology  Jan 2005 
 - 204-12 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Comparative Study; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0165-5728 
<br/><br/><label>Standard No.: </label>10.1016/j.jneuroim.2004.08.014  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Cell Count--methods<br/>Cells, Cultured<br/>Dendritic Cells--drug effects<br/>Disability Evaluation<br/>Enzyme-Linked Immunosorbent Assay--methods<br/>Female<br/>Flow Cytometry--methods<br/>Humans<br/>Interferon-beta--pharmacology<br/>Interleukin-10--metabolism<br/>Interleukin-3 Receptor alpha Subunit<br/>Interleukin-6--metabolism<br/>Male<br/>Middle Aged<br/>Multiple Sclerosis--drug therapy<br/>Receptors, Interleukin-3--metabolism<br/>Sendai virus--pathogenicity<br/>Simplexvirus--pathogenicity